Recent Quotes (30 days)

You have no recent quotes
chg | %

Takeda Pharmaceutical Co Ltd news

   Watch this stock
Showing stories 1 - 10 of about 110   

Articles published

4502 4,716.50 +30.00 (0.64%)
price chart
Takeda Pharmaceutical Co (TKPYY) Releases Quarterly Earnings Results
Takeda Pharmaceutical Co Ltd logo Takeda Pharmaceutical Co (NASDAQ:TKPYY) posted its quarterly earnings results on Friday. The company reported $0.21 earnings per share for the quarter, Analyst Ratings.
Related articles »  
Strong Traded Stocks of: MusclePharm Corporation (MSLP), Takeda ...
Takeda Pharmaceutical Co Ltd (ADR) (OTCMKTS:TKPYY), in a consortium with PT Wijaya Karya Tbk , was awarded an onshore lumpsum contract by PT Pertamina EP for the Matindok Gas Development project situated in Central Sulawesi, Indonesia.
Active Movers -NOVUS ACQ & DEV CORP (OTCMKTS:NDEV),Takeda ...
Takeda Pharmaceutical Co Ltd (ADR) (OTCMKTS:TKPPY)is engaged in supplying pharmaceutical products worldwide. The company provides products in various therapeutic areas, including cardiovascular and metabolic, oncology, central nervous system, ...
Related articles »  
Penny Stocks in Focus: Cellceutix Corp (OTCMKTS:CTIX), Takeda ...
Cellceutix Corp (OTCMKTS:CTIX),a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology, and antibiotic applications, reported that the Company has just received the final toxicology report for Brilacidin-OM.
Eye-Catching Stocks - Amadeus IT Holding SA (AMADY),Takeda ...
Takeda Pharmaceutical Co Ltd (ADR) (OTCMKTS:TKPPY) is engaged in supplying pharmaceutical products worldwide. The company provides products in various therapeutic areas, including cardiovascular and metabolic, oncology, central nervous system, ...
AMAG Pharmaceuticals Appoints Robert Blood as Vice President of Legal Affairs ...
AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company that markets Feraheme(R) (ferumoxytol) Injection and MuGard(R) Mucoadhesive Oral Wound Rinse in the United States.
Related articles »  
Amgen gives investors a double dose of bad news after the close
Onyx spokeswoman Danielle Bertrand said two other Phase 3 tests are being conducted on Kyprolis to measure its effectiveness against Velcade, a product of Japan's Takeda Pharmaceutical Co. Ltd. /quotes/zigman/198337/delayed JP:4502 Takeda, in fact, ...
Related articles »  
FDA Approves VELCADE´┐Ż (bortezomib) Retreatment in Patients with Multiple ...
CAMBRIDGE, Mass., Aug 10, 2014 (BUSINESS WIRE) -- Millennium: The Takeda Oncology Company with its parent company, Takeda Pharmaceutical Company Limited , today announced that the U.S. Food and Drug Administration (FDA) has approved ...
FDA approves VELCADE retreatment in patients with multiple myeloma  Pharmaceutical Business Review
US FDA approves Velcade for retreatment of adult patients with multiple myeloma  pharmabiz.com
Related articles »  
FDA Approves VELCADE(R) (bortezomib) Retreatment in Patients with Multiple ...
Millennium: The Takeda Oncology Company with its parent company, Takeda Pharmaceutical Company Limited (TSE:4502), today announced that the U.S.
Related articles »  
Takeda Barred From Doubling Up Patent Claims In Drug Case
Law360, New York (August 05, 2014, 5:37 PM ET) -- A California federal judge has tossed Takeda Pharmaceutical Co. Ltd.'s claim seeking declaratory judgment that Mylan Inc.'s planned generic version of the acid reflux drug Dexilant will infringe its ...
Related articles »